RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
FRONTIERS IN ONCOLOGY
Collezione AOU Novara

Items : 13

Neutrophil/lymphocyte ratio: a potential biomarker in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors. in Frontiers in oncology / Front Oncol. 2025 May 6;15:1557652. doi: 10.3389/fonc.2025.1557652. eCollection 2025.

2025
AOU Novara

Caterino M; Lo Giudice G; Damiano V; Perri F; Giordano G; Ciardiello D; Mirabile A; Pirozzi M; Sponghini AP; Ricci V; Montella L; Addeo R; Vignani F; Famiglietti V; Farese S; Di Lorenzo S; Ciardiello F; Fasano M;

Editorial: Ano-rectal and gastro-esophageal cancer: diving into diagnostic and therapeutic imaging modalities for radiotherapy. in Frontiers in oncology / Front Oncol. 2023 Aug 31;13:1276334. doi: 10.3389/fonc.2023.1276334. eCollection 2023.

2023
AOU Novara

Deantonio L; De Bari B; Franco P;

Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi. in Frontiers in oncology / Front Oncol. 2023 Mar 10;13:1120967. doi: 10.3389/fonc.2023.1120967. eCollection 2023.

2023
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Fama A; Olivieri J; Zaja F; Rotondo F; Kovalchuk S; Cattina F; Cenfra N; Ciavarella S; Castellino A; Bozzoli V; Boccomini C; Annibali O; Nicolosi M; Petrucci L; Meli E; Cocito F; Bigliardi S; Margiotta-Casaluci G;

Corrigendum: Results of the ECHO (Eating habits CHanges in Oncologic patients) Survey: An Italian Cross-Sectional Multicentric Study to Explore Dietary Changes and Dietary Supplement Use, in Breast Cancer Survivors. in Frontiers in oncology / Front Oncol. 2022 Feb 2;12:851999. doi: 10.3389/fonc.2022.851999. eCollection 2022.

2022
AOU Novara

Caprara G; Tieri M; Fabi A; Guarneri V; Falci C; Dieci MV; Turazza M; Ballardini B; Bin A; Cinieri S; Vici P; Montagna E; Zamagni C; Mazzi C; Modena A; Marchetti F; Verzè M; Ghelfi F; Titta L; Nicolis F; Gori S;

Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms. in Frontiers in oncology / Front Oncol. 2021 Oct 26;11:777730. doi: 10.3389/fonc.2021.777730. eCollection 2021.

2021
AOU Novara

Moia R; Cittone MG; Boggione P; Manfredi GF; Favini C; Awikeh B; Pedrinelli AR; Mahmoud AM; Nicolosi M; Bellan M; Sainaghi PP; Pirisi M; Gaidano G; Patriarca A; Rigamonti C;

CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL). in Frontiers in oncology / Front Oncol. 2021 Nov 5;11:730194. doi: 10.3389/fonc.2021.730194. eCollection 2021.

2021
AOU Città della Salute di Torino
AOU Novara

Chiappella A; Rusconi C; Ferreri AJM; Cabras MG; Annibali O; Gentile M; Olivieri A; Loseto G; Arcari A; Tisi MC; Nassi L; Di Rocco A; Gini G; Balzarotti M;

Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana Linfomi. in Frontiers in oncology / Front Oncol. 2021 Dec 6;11:789891. doi: 10.3389/fonc.2021.789891. eCollection 2021.

2021
AOU Novara

Ballotta L; Zinzani PL; Pileri S; Bruna R; Tani M; Casadei B; Tabanelli V; Volpetti S; Luminari S; Corradini P; Lucchini E; Tisi MC; Merli M; Re A; Varettoni M; Pesce EA; Zaja F;

Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia. in Frontiers in oncology / Front Oncol. 2021 Aug 2;11:684621. doi: 10.3389/fonc.2021.684621. eCollection 2021.

2021
AOU Novara

Morabito F; Tripepi G; Moia R; Recchia AG; Boggione P; Mauro FR; Bossio S; D'Arrigo G; Martino EA; Vigna E; Storino F; Fronza G; Di Raimondo F; Rossi D; Condoluci A; Colombo M; Fais F; Fabris S; Foa R; Cutrona G; Gentile M; Montserrat E; Gaidano G; Ferrarini M; Neri A;

Results of the ECHO (Eating habits CHanges in Oncologic patients) Survey: An Italian Cross-Sectional Multicentric Study to Explore Dietary Changes and Dietary Supplement Use, in Breast Cancer Survivors. in Frontiers in oncology / Front Oncol. 2021 Nov 1;11:705927. doi: 10.3389/fonc.2021.705927. eCollection 2021.

2021
AOU Novara

Breast Cancer Survivorship, Quality of Life, and Late Toxicities. in Frontiers in oncology / Front Oncol. 2020 Jun 16;10:864. doi: 10.3389/fonc.2020.00864. eCollection 2020.

2020
AOU Novara

Nardin S; Mora E; Varughese FM; D'Avanzo F; Vachanaram AR; Rossi V; Saggia C; Rubinelli S; Gennari A;

Integrating Biological Advances Into the Clinical Management of Breast Cancer Related Lymphedema. in Frontiers in oncology / Front Oncol. 2020 Apr 2;10:422. doi: 10.3389/fonc.2020.00422. eCollection 2020.

2020
AOU Novara

Invernizzi M; Lopez G; Michelotti A; Venetis K; Sajjadi E; De Mattos-Arruda L; Ghidini M; Runza L; de Sire A; Boldorini R; Fusco N;

Ramadan Fasting and Patients with Cancer: State-of-the-Art and Future Prospects. in Frontiers in oncology / Front Oncol. 2016 Feb 10;6:27. doi: 10.3389/fonc.2016.00027. eCollection 2016.

2016
AOU Novara

Bragazzi NL; Briki W; Khabbache H; Rammouz I; Chamari K; Demaj T; Re TS; Zouhir M;

Targeting PI3K/Akt/mTOR Signaling in Cancer. in Frontiers in oncology / Front Oncol. 2014 Apr 14;4:64. doi: 10.3389/fonc.2014.00064. eCollection 2014.

2014
AOU Novara

Porta C; Paglino C; Mosca A;